<DOC>
	<DOCNO>NCT00835523</DOCNO>
	<brief_summary>The aim study explore concept GnRH-agonist trigger combination elective cryopreservation 2PN oocyte large scale pragmatic clinical setting . The question ask : `` Does GnRH-agonist trigger cryopreservation work '' , term efficacy safety , apply large cohort patient , number different centre different clinical routine .</brief_summary>
	<brief_title>Ovarian Hyperstimulation Syndrome ( OHSS ) Prevention With Agonist</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<criteria>Indication IVF ICSI Age &lt; 40 year &lt; 4 fail previous IVF attempt embryo transfer ovarian stimulation GnRHantagonist gonadotrophins &gt; 20 follicle &gt; 11 mm mean diameter E2 &gt; 4500 pg/ml day , plan administer hCG willing participate able consent patient previously receive GnRHagonist trigger final oocyte maturation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>frozen-thawed embryo replacement</keyword>
	<keyword>GnRH agonist</keyword>
	<keyword>GnRH antagonist</keyword>
	<keyword>ovarian hyperstimulation</keyword>
</DOC>